重組 DNA 技術市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

概要

2022年全球重組DNA技術市場規模達7,298億美元。展望未來， IMARC Group預計到2028年市場規模將達到9,668億美元，2022-2028年複合年成長率（CAGR）為4.80%。

重組 DNA 技術的出現徹底改變了生物學的發展，並為創新提供了新的機會。它也稱為基因工程，目前廣泛用於改變生物體外部的遺傳物質，並在活生物體中獲得改進的和所需的特性。它包括透過適當的載體插入具有所需基因序列的多個來源的 DNA 片段。除此之外，它還有助於安全、經濟且充足地生產飲食和對抗健康問題所需的重要蛋白質。因此，它具有多學科應用和改善健康、增強食物資源和抵抗不同不利環境影響的巨大潛力。

重組DNA技術市場趨勢：

重組DNA技術主要透過開發新的疫苗和藥物來改善不同的健康狀況。再加上診斷試劑盒、監測設備和新治療方法的開發而改進的治療策略，是推動市場成長的關鍵因素之一。此外，對基因改造生物（GMO）的研究增加，其中包括被視為生物分解者和清潔燃料生產者的微生物。這可以歸因於快速的城市化、全球人口的成長、耕地的減少、糧食短缺的嚴重加劇以及基改作物的日益採用。除此之外，重組DNA技術為醫學遺傳學和生物醫學領域開發多種具有即時效果的治療產品提供了多種創新機會，其應用正在各個領域不斷擴大。例如，將重組 DNA 技術與有效基因療法結合，以正常基因取代有缺陷的基因，以及生產用於臨床研究、研究和疾病診斷的抗原特異性抗體，預計將在未來幾年推動市場成長。

本報告回答的關鍵問題：

• 迄今為止，全球重組 DNA 技術市場表現如何，未來幾年又將如何表現？
• COVID-19 對全球重組 DNA 技術市場有何影響？
• 主要區域市場有哪些？
• 基於產品的市場區隔是什麼？
• 基於組件的市場區隔是什麼？
• 基於應用程式的市場區隔是什麼？
• 基於最終用戶的市場區隔是什麼？
• 產業價值鏈的各個階段是什麼？
• 該行業的關鍵促進因素和挑戰是什麼？
• 全球重組DNA技術市場的結構如何？誰是主要參與者？
• 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

• 研究目的
• 利害關係人
• 資料來源
  • 主要資源
  • 二手資料
• 市場預測
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章：執行摘要

第 4 章：簡介

• 概述
• 主要行業趨勢

第 5 章：全球重組 DNA 技術市場

• 市場概況
• 市場業績
• COVID-19 的影響
• 市場預測

第 6 章：按產品分類的市場區隔

• 醫療的
  • 市場走向
  • 關鍵環節
    • 治療劑
    • 人類蛋白質
    • 疫苗
  • 市場預測
• 非醫療
  • 市場走向
  • 關鍵環節
    • 生物技術作物
    • 特種化學品
    • 其他
  • 市場預測

第 7 章：按成分分類的市場區隔

• 表達系統
  • 市場走向
  • 市場預測
• 克隆載體
  • 市場走向
  • 市場預測

第 8 章：按應用分類的市場區隔

• 食品和農業
  • 市場走向
  • 市場預測
• 健康與疾病
  • 市場走向
  • 市場預測
• 環境
  • 市場走向
  • 市場預測
• 其他
  • 市場走向
  • 市場預測

第 9 章：最終用戶的市場區隔

• 生物技術和製藥公司
  • 市場走向
  • 市場預測
• 學術和政府研究機構
  • 市場走向
  • 市場預測
• 其他
  • 市場走向
  • 市場預測

第 10 章：按地區分類的市場細分

• 北美洲
  • 美國
    • 市場走向
    • 市場預測
  • 加拿大
    • 市場走向
    • 市場預測
• 亞太
  • 中國
    • 市場走向
    • 市場預測
  • 日本
    • 市場走向
    • 市場預測
  • 印度
    • 市場走向
    • 市場預測
  • 韓國
    • 市場走向
    • 市場預測
  • 澳洲
    • 市場走向
    • 市場預測
  • 印尼
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測
• 歐洲
  • 德國
    • 市場走向
    • 市場預測
  • 法國
    • 市場走向
    • 市場預測
  • 英國
    • 市場走向
    • 市場預測
  • 義大利
    • 市場走向
    • 市場預測
  • 西班牙
    • 市場走向
    • 市場預測
  • 俄羅斯
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測
• 拉丁美洲
  • 巴西
    • 市場走向
    • 市場預測
  • 墨西哥
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測
• 中東和非洲
  • 市場走向
  • 按國家/地區分類的市場細分
  • 市場預測

第 11 章：SWOT 分析

• 概述
• 優勢
• 弱點
• 機會
• 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

• 概述
• 買家的議價能力
• 供應商的議價能力
• 競爭程度
• 新進入者的威脅
• 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

• 市場結構
• 關鍵參與者
• 關鍵參與者簡介
  • Amgen Inc
  • Cibus
  • F.Hoffmann-La Roche Ltd
  • GenScript
  • GlaxoSmithKline plc.
  • Horizon Discovery Group plc
  • Merck KGaA
  • New England Biolabs
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi SA
  • Syngene International Ltd (Biocon Limited)

Abstract

The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.80% during 2022-2028.

The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.

Recombinant DNA Technology Market Trends:

The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, component, application and end user.

Breakup by Product:

Medical

Therapeutic Agent

Human Protein

Vaccines

Non-Medical

Biotech Crops

Specialty Chemicals

Others

Breakup by Component:

Expression System

Cloning Vector

Breakup by Application:

Food and Agriculture

Health and Disease

Environment

Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies

Academic and Government Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).

Key Questions Answered in This Report:

• How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global recombinant DNA technology market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global recombinant DNA technology market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Recombinant DNA Technology Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Medical
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Therapeutic Agent
    • 6.1.2.2 Human Protein
    • 6.1.2.3 Vaccines
  • 6.1.3 Market Forecast
• 6.2 Non-Medical
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Biotech Crops
    • 6.2.2.2 Specialty Chemicals
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast

7 Market Breakup by Component

• 7.1 Expression System
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cloning Vector
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Food and Agriculture
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Health and Disease
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Environment
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Biotechnology and Pharmaceutical Companies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic and Government Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Amgen Inc
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Cibus
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 F.Hoffmann-La Roche Ltd
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 SWOT Analysis
  • 15.3.4 GenScript
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 GlaxoSmithKline plc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Horizon Discovery Group plc
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Merck KGaA
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 New England Biolabs
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Novo Nordisk A/S
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Pfizer Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Sanofi S.A
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Syngene International Ltd (Biocon Limited)
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis

List of Figures

• Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
• Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2017-2022
• Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2023-2028
• Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2022
• Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2022
• Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2022
• Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2022
• Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2022
• Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
• Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
• Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2022
• Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
• Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
• Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
• Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2022 and 2028
• Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2023-2028
• Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2023-2028
• Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2023-2028
• Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2023-2028
• Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2023-2028
• Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
• Table 8: Global: Recombinant DNA Technology Market: Key Players